TheStreet: Stock Quotes, Financial Market News, & Investment Advice

Most Commented Story

FDA Raises Concerns About Cell Therapeutics' Cancer Drug

Ahead of a Feb. 10 advisory panel meeting, regulators say pivotal trial of pixantrone was too small; they also express concern about heart safety of drug.

Commentary

Intel to Finally Make Money on Atom, Part 2

After analyzing new information, I believe Intel stands to make about $1.3 billion, not the previously estimated $1.6 billion, on the Atom for just netbooks.

Commentary

Fighting the Herd Mentality

When investing, you must do the opposite of the masses during times of extreme price behavior.

Vote in our Poll

Which CEO Should Go On 'Undercover Boss'?

Which CEO stands to benefit the most from an appearance on CBS' new reality show 'Undercover Boss'? Take our poll and see what TheStreet says.

Videos

Strong-Dollar Stocks

NEW YORK (TheStreet) -- A stronger U.S. dollar is hurting stocks and commodities, creating some long-term buying opportunities.

Videos

They Just Don't Get CIT!

WESTCHESTER COUNTY, N.Y. -- Marek Fuchs, TheStreet's media critic, infiltrates media thinking on CIT.

Videos

Sell ETRADE!: Against the Grain

WESTCHESTER COUNTY, N.Y. -- Marek Fuchs tells ETRADE traders to flee (not welcome) a price war.

Stanley Bing

I Want My iPad!

The Apple iPad just might be the ultimate thing that cancels out all the others and dominates our lives so we never have to leave our homes.

Best in Class Business

First Niagara Stays Aggressive: Best in Class

First Niagara Financial

In Memoriam

Dave Morrow Memorial Prize Established

The new "Dave Morrow Prize for Audacious and Talented Financial Journalists" will honor the former editor in chief of TheStreet.com who passed away this week.

Between the Lines
Dave's Daily
Dave's Daily: Rainy Days & Mondays

Markets and ETF expert Dave Fry says investors lost their bullish conviction as the day wore on and jitters rose about Bernanke's plans for interest rates. This edition of Dave's Daily also looks at CVS/Caremark, Home Depot and related ETFs like XLY and XLB.

Winners & Losers
'Fast Money' Recap: A Big Correction

Dennis Gartman told the trading panel that he sees a correction of more than 10% coming.

TheStreet Ratings
Insurance Stocks With the Biggest Volatility

Insurance stocks have barely budged in the past month. These companies, however, are still volatile, providing investment opportunities.

Biotech
FDA Raises Concerns About Cell Therapeutics' Cancer Drug

Ahead of a Feb. 10 advisory panel meeting, regulators say pivotal trial of pixantrone was too small; they also express concern about heart safety of drug.

Banks & Insurers
Which CEO Should Go On 'Undercover Boss'?

Which CEO stands to benefit the most from an appearance on CBS' new reality show 'Undercover Boss'? Take our poll and see what TheStreet says.

Earnings
Six Best & Worst Health Care IT Stocks

Health care information stocks are being punished by investors early in 2010, raising debate as to whether the selling is overdone or a sea-change in invesor sentiment on the once-hot sector.

ETFs
Toyota Weighs on Japan ETF

The latest problems with the automaker is one of the many factors that dictate the direction of the ETF.

Technology
Which CEO Should Go On 'Undercover Boss'?

Which CEO stands to benefit the most from an appearance on CBS' new reality show 'Undercover Boss'? Take our poll and see what TheStreet says.

IPOs
2010 IPO Outlook

NEW YORK(TheStreet) - - IPO experts from Renaissance Capital give the outlook for the IPO calendar in 2010.

Try RealMoney Free Trial Now

Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
9,908.39 1,056.74 2,126.05 35.92
Oil *
69.92
DOWN
103.84
DOWN
9.44
DOWN
15.07
UP
0.46
10 Yr
3.59%
SPDR Gold
104.05
-1.04%
-0.89%
-0.70%
+1.30%
Data delayed 20 minutes

More From TheStreet

Latest Headlines
  • Top Rated Stocks from TheStreet Ratings
  • Find returns with the Dividend Calendar

Brokerage Partners

TheStreet Premium Services

All Services

Special Advertising Features